Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target.

Cesaro, Arturo; Riccio, Carmine; Calabrò, Paolo

Cesaro, Arturo; Riccio, Carmine; Calabrò, Paolo.

Affiliation

Cesaro A; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples; Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta. arturocesaro@hotmail.it.
Riccio C; Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta. carmine.riccio8@icloud.com.
Calabrò P; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples; Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta. paolo.calabro@unicampania.it.

Monaldi Arch Chest Dis ; 91(2)2021 May 04.

Article in En | MEDLINE | ID: mdl-33942600

Subject(s)

COVID-19/immunology; Cardiovascular Diseases/prevention & control; Heart Disease Risk Factors; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hyperlipidemias/drug therapy; Hypolipidemic Agents/therapeutic use; COVID-19/complications; COVID-19/mortality; COVID-19/physiopathology; Cardiovascular Diseases/complications; Cardiovascular Diseases/drug therapy; Deprescriptions; Humans; Hyperlipidemias/complications; Primary Prevention; SARS-CoV-2; Secondary Prevention

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Heart Disease Risk Factors / COVID-19 / Hyperlipidemias / Hypolipidemic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Monaldi Arch Chest Dis Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google